Zacharias M. , Clarke RS, Dundee JW, Johnston SB: Evaluation of three preparations of etomidate . Br J Anaesth50:925-929, 1978
2.
Zacharias M. , Clarke RS, Dundee JW, Johnston SB: Venous sequelae following etomidate. Br J Anaesth51:779-783, 1979
3.
Meuldermans WE, Heykants IJ: The plasma protein binding and distribution of etomidate in dog, rat and human blood. Archives Internationales de Pharmacodynamie et de Therapie221:150-162,1976
4.
Van Hamme MJ , Ghoneim MM, Ambre JJ: Pharmacokinetics of etomidate, a new intravenous anesthetic. Anesthesiology49:274-277, 1978
5.
Schuttler J. , Wilms M., Lauven PM, et al: [Pharmacokinetics of etomidate in man (author's transl)]. [German] Pharmakokinetische Untersuchungen uber Etomidat beim Menschen. Anaesthesist29:658-661, 1980
6.
Fragen RJ, Avram MJ, Henthorn TK, Caldwell NJ: A pharmacokinetically designed etomidate infusion regimen for hypnosis. Anesth Analg62:654-660, 1983
7.
Heykants JJ, Meuldermans WE, Michiels LJ, et al: Distribution, metabolism and excretion of etomidate, a short-acting hypnotic drug, in the rat: Comparative study of (R)-(+)-(-)-Etomidate. Archives Internationales de Pharmacodynamie et de Therapie216:113-129,1975
8.
Evans RH, Hill RG: GABA-mimetic action of etomidate. Experientia34:1325-1327, 1978
9.
Robertson B. : Actions of anaesthetics and avermectin on GABAA chloride channels in mammalian dorsal root ganglion neurones. Br J Pharmacol98:167-176,1989
10.
Willow M.: A comparison of the actions of pentobarbitone and etomidate on [3H]GABA binding to crude synaptosomal rat brain membranes. Brain Res220:427-431, 1981
11.
Uchida I., Kamatchi G., Burt D., Yang J.: Etomidate potentiation of GABAA receptor-gated current depends on the subunit composition. Neurosci Lett185:203-206, 1995
12.
Renou AM, Vernhiet J., Macrez P., et al: Cerebral blood flow and metabolism during etomidate anaesthesia in man. BrJ Anaesth50:1047-1051, 1978
13.
Moss E., Powell D., Gibson RM, McDowall DG: Effect of etomidate on intracranial pressure and cerebral perfusion pressure . Br J Anaesth51:347-352, 1979
14.
Cold GE, Eskesen V., Eriksen H., et al: CBF and CMRO2 during continuous etomidate infusion supplemented with N2O and fentanyl in patients with supratentorial cerebral tumour: A dose-response study. Acta Anaesthesiol Scand29:490-494, 1985
15.
Cold GE, Madsen JB, Knudsen L.: Measurement of cerebral blood flow (CBF) with the Kety and Schmidt technique during craniotomy. Agressologie32:345-351, 1991
16.
Sear JW, Walters FJ, Wilkins DG, Willatts SM: Etomidate by infusion for neuroanaesthesia: Kinetic and dynamic interactions with nitrous oxide. Anaesthesia39:12-18, 1984
17.
Cold GE: Etomidate used for brain neurosurgical anaesthesia: The effect upon cerebral circulation and metabolism. Agressologie32:412-416, 1991
18.
Dearden NM, McDowall DG: Comparison of etomidate and althesin in the reduction of increased intracranial pressure after head injury. Br J Anaesth57:361-368, 1985
19.
Wagner RI, White PF, Kan PB, et al: Inhibition of adrenal steroidogenesis by the anesthetic etomidate . N Engl J Med310:1415-1421, 1984
20.
Wauquier A. : Brain protective properties of etomidate and flunarizine. J Cereb Blood Flow Metab2:S53-S56, 1982 (Suppl 1)
21.
Wauquier A. : Profile of etomidate: A hypnotic, anticonvulsant and brain protective compound [Review]. Anaesthesia38:26-33, 1983
22.
Ashton D., van Reempts J., Wauquier A.: Behavioural, electroencephalographic and histological study of the protective effect of etomidate against histotoxic dysoxia produced by cyanide. Archives Internationales de Pharmacodynamie et de Therapie254:196-213, 1981
23.
Van Reempts J, Borgers M., Van Eyndhoven J, Hermans C.: Protective effects of etomidate in hypoxic-ischemic brain damage in the rat: A morphologic assessment . Exp Neurol76:181-195, 1982
24.
Tulleken CA , van Dieren A., Jonkman J., Kalenda Z.: Clinical and experimental experience with etomidate as a brain protective agent. J Cereb Blood Flow Metab2:S92-S97, 1982 (Suppl 1)
25.
Sano T., Patel PM, Drummond JC, Cole DJ: A comparison of the cerebral protective effects of etomidate, thiopental, and isoflurane in a model of forebrain ischemia in the rat. Anesth Analg76:990-997, 1993
26.
Koorn R., Brannan TS, Martinez-Tica J., et al: Effect of etomidate on in vivo ischemia-induced dopamine release in the corpus striatum of the rat: A study using cerebral microdialysis. Anesth Analg78:73-79, 1994
27.
Patel PM, Goskowicz RI, Drummond JC, Cole DJ: Etomidate reduces ischemia-induced glutamate release in the hippocampus in rats subjected to incomplete forebrain ischemia. Anesth Analg80:933-939, 1995
28.
Cold GE, Eskesen V., Eriksen H., Blatt Lyon B.: Changes in CMRO2, EEG and concentration of etomidate in serum and brain tissue during craniotomy with continuous etomidate supplemented with N2O and fentanyl. Acta Anaesthesiol Scand30:159-163, 1986
29.
Samson D., Batjer HH, Bowman G., et al: A clinical study of the parameters and effects of temporary arterial occlusion in the management of intracranial aneurysms. Neurosurgery34:22-28, 1994
30.
Drummond JC , Cole DJ, Patel PM, Reynolds LW: Focal cerebral ischemia during anesthesia with etomidate, isoflurane, or thiopental: A comparison of the extent of cerebral injury. Neurosurgery37:742-748, 1995
31.
Guo J., White JA, Batjer HH: Limited protective effects of etomidate during brainstem ischemia in dogs . J Neurosurg82:278-283, 1995
32.
Ghoneim MM, Yamada T.: Etomidate: A clinical and electroencephalographic comparison with thiopental . Anesth Analg56:479-485, 1977
33.
Koht A., Schutz W., Schmidt G., et al: Effects of etomidate, midazolam, and thiopental on median nerve somatosensory evoked potentials and the additive effects of fentanyl and nitrous oxide. Anesth Analg67:435-441, 1988
34.
McPherson RW , Sell B., Traystman RJ: Effects of thiopental, fentanyl, and etomidate on upper extremity somatosensory evoked potentials in humans. Anesthesiology65:584-589, 1986
35.
Sloan TB, Ronai AK, Toleikis JR, Koht A.: Improvement of intraoperative somatosensory evoked potentials by etomidate . Anesth Analg67:582-585, 1988
36.
Kalkman CJ, Drummond JC, Ribberink AA, et al: Effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans . Anesthesiology76:502-509, 1992
Reddy RV, Moorthy SS, Dierdorf SF, et al: Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg77:1008-1011, 1993
39.
Carlos R., Innerarity S.: Effect of premedication on etomidate anaesthesia. Br J Anaesth51:1159-1162, 1979
40.
Ebrahim ZY, DeBoer GE, Luders H., et al: Effect of etomidate on the electroencephalogram of patients with epilepsy. Anesth Analg65:1004-1006, 1986
41.
Hoffmann P. , Schockenhoff B.: [Etomidate as an anticonvulsive agent]. [German] Etomidat als antikonvulsive Substanz. Anaesthesist33:142-144, 1984
42.
Avramov MN, Husain MM, White PF: The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg81:596-602, 1995
43.
Yeoman P., Hutchinson A., Byrne A., et al: Etomidate infusions for the control of refractory status epilepticus . Intensive Care Medicine15:255-259, 1989
Hsieh JC, Shih YS, Hwang LD, et al: Activation of epileptogenic activities by etomidate in electrocorticoencephalography (ECoG) during operation for epilepsy. Ma Tsui Hsueh Tsa Chi Anaesthesiologica Sinica28:127-135, 1990
46.
Giese JI, Stanley TH: Etomidate: A new intravenous anesthetic induction agent. [Review]. Pharmacotherapy3:251-258, 1983
47.
Giese JI, Stockham RJ, Stanley TH, et al: Etomidate versus thiopental for induction of anesthesia. Anesth Analg64:871-876, 1985
48.
Choi SD, Spaulding BC, Gross JB, Apfelbaum JI: Comparison of the ventilatory effects of etomidate and methohexital. Anesthesiology62:442-447, 1985
49.
Morgan M., Lumley J., Whitwam JG: Respiratory effects of etomidate. Br J Anaesth49:233-236, 1977
50.
Kettler D., Sonntag H., Donath U., et al: [Haemodynamics, myocardial mechanics, oxygen requirement and oxygenation of the human heart during induction of anaesthesia with etomidate (author's transl) ]. [German] Hamodynamik, Myokardmechanik, Sauerstoffbedarf und Sauerstoffversorgung des menschlichen Herzens unter Narkoseeinleitung mit Etomidate. Anaesthesist23:116-121, 1974
51.
Criado A., Maseda J., Navarro E., et al: Induction of anaesthesia with etomidate: Haemodynamic study of 36 patients. Br J Anaesth52:803-806, 1980
52.
Doenicke A. , Gabanyi D., Lemce H., Schurk-Bulich M: [Haemodynamics and myocardial function after administration of three short-acting IV hypnotics, etomidate, propanidid, methohexital (author's transl)]. [German] Kreislaufverhalten und Myokardfunktion nach drei kurzwirkenden i.v. Hypnotica Etomidate, Propanidid, Methohexital. Anaesthesist23:108-115, 1974
53.
Gooding JM, Corssen G.: Effect of etomidate on the cardiovascular system. Anesth Analg56:717-719, 1977
54.
Hempelmann G., Piepenbrock S., Hempelmann W., Karliczek G.: Influence of althesine and etomidate on blood gases (continuous PO2 monitoring) and hemodynamics in man. Acta Anaesthesiol Belg25:402-412, 1974
55.
Scorgie B.: Etomidate infusion: Its use in anaesthesia for general surgery. Anaesthesia38:63-65, 1983
56.
Gauss A., Heinrich H., Wilder-Smith OH: Echocardiographic assessment of the haemodynamic effects of propofol: A comparison with etomidate and thiopentone. Anaesthesia46:99-105, 1991
57.
Stowe DF, Bosnjak ZJ, Kampine JP: Comparison of etomidate, ketamine, midazolam, propofol, and thiopental on function and metabolism of isolated hearts. Anesth Analg74:547-558, 1992
58.
Kissin I., Motomura S., Aultman DF, Reves JG: Inotropic and anesthetic potencies of etomidate and thiopental in dogs. Anesth Analg62:961-965, 1983
59.
Komai H., DeWitt DE, Rusy BF: Negative inotropic effect of etomidate in rabbit papillary muscle. Anesth Analg64:400-404, 1985
60.
Mattheussen M., Housmans PR: Mechanism of the direct, negative inotropic effect of etomidate in isolated ferret ventricular myocardium. Anesthesiology79:1284-1295, 1993
61.
Boyle WA, White PF, Rending SV: Negative inotropic effects of propofol versus etomidate and thiopental on rabbit papillary muscle. Anesth Analg68:S35, 1989 (abstract)
62.
Gelissen HP, Epema AH, Henning RH, et al: Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology84:397-403, 1996
63.
Tarnow J., Hess W., Klein W.: Etomidate, alfathesin and thiopentone as induction agents for coronary artery surgery. Can Anaesth Soc J27:338-344, 1980
64.
Lindeburg T. , Spotoft H., Bredgaard Sorensen M, Skovsted P.: Cardiovascular effects of etomidate used for induction and in combination with fentanyl-pancuronium for maintenance of anaesthesia in patients with valvular heart disease. Acta Anaesthesiol Scand26:205-208, 1982
65.
Gooding JM, Weng JT, Smith RA, et al: Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease. Anesth Analg58:40-41, 1979
66.
Hempelmann G., Hempelmann W., Piepenbrock S., et al: [The influence of etomidate on blood gases and haemodynamics in patients with myocardial disease (author's transl)]. [German] Die Beeinflussung der Blutgase und Hamodynamik durch Etomidate bei myokardial vorgeschadigten Patienten. Anaesthesist23:423-429, 1974
67.
De Hert SG, Vermeyen KM, Adriaensen HF: Influence of thiopental, etomidate, and propofol on regional myocardial function in the normal and acute ischemic heart segment in dogs. Anesth Analg70:600-607, 1990
68.
Patschke D. , Bruckner JB, Eberlein HJ, et al: Effects of althesin, etomidate and fentanyl on haemodynamics and myocardial oxygen consumption in man. Can Anaesth Soc J24:57-69,1977
69.
Stockham RJ , Stanley TH, Pace NI, et al: Induction of anesthesia with fentanyl or fentanyl plus etomidate in high-risk patients. J Cardiothorac Anesth1:19-23, 1987
70.
Larsen R., Rathgeber J., Bagdahn A., et al: Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients. A comparison with etomidate. Anaesthesia43:25-31, 1988
71.
Haessler R. , Madler C., Klasing S., et al: Propofol/fentanyl versus etomidate/fentanyl for the induction of anesthesia in patients with aortic insufficiency and coronary artery disease. J Cardiothorac Vasc Anesth6:173-180, 1992
72.
Ebert TJ, Muzi M., Berens R., et al: Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology76:725-733, 1992
73.
Poterack KA , Kampine JP, Schmeling WT: Effects of isoflurane, midazolam, and etomidate on cardiovascular responses to stimulation of central nervous system pressor sites in chronically instrumented cats. Anesth Analg73:64-75, 1991
74.
Christopher MM, Eckfeldt JH, Eaton JW: Propylene glycol ingestion causes D-lactic acidosis. Lab Invest62:114-118, 1990
75.
Demey HE, Daelemans RA, Verpooten GA: Propylene glycol-induced side effects during nitroglycerin therapy. Intensive Care Med14:221-226, 1988
76.
Martin G., Finberg L.: Propylene glycol: A potentially toxic vehicle in liquid dosage form. Pediatrics77:877-878, 1970
77.
Flinger CL, Jack R., Twiggs GA, Raisys VA: Hyperosmolality induced by propylene glycol. JAMA253:1606-1609, 1985
78.
Bretschneider H.: Osmolalities of commercially supplied drugs often used in anesthesia. Anesth Analg66:361-362, 1987
79.
Doenicke A. , Roizen MF, Nebauer AE, et al: A comparison of two formulations for etomidate, 2-hydroxypropyl-betacyclodextrin (HPCD) and propylene glycol. Anesth Analg79:933-939,1994
80.
Doenicke A. , Nebauer AE, Hoernecke R., et al: Osmolalities of propylene glycol containing drug formulations for parenteral use: Should propylene glycol be used as a solvent. Anesth Analg75:431-435, 1992
81.
Doenicke A. , Kugler A., Vollmann N., et al: [Etomidate using a new solubilizer. Experimen tal clinical studies on venous tolerance and bioavailability]. [German] Etomidat mit einem neuen Losungsvermittler. Klinischexperimentelle Untersuchungen zur Venenvertraglichkeit und Bioverfugbarkeit. Anaesthesist39:475-480, 1990
82.
Ledingham IM , Watt I.: Influence of sedation on mortality in critically ill multiple trauma patients. Lancet1:1270, 1983
83.
Wagner RI, White PF: Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology61:647-651, 1984
84.
Fragen RJ, Shanks CA, Molteni A., Avram MJ: Effects of etomidate on hormonal responses to surgical stress. Anesthesiology61:652-656, 1984
85.
Preziosi P. , Vacca M.: Adrenocortical suppression and other endocrine effects of etomidate. [Review]. Life Sci42:477-489, 1988
86.
Sear JW, Edwards CR, Atherden SM: Dual effect of etomidate on mineralocorticoid biosynthesis. Acta Anaesthesiol Belg39:87-94, 1988
87.
Longnecker DE: Stress free: To be or not to be?Anesthesiology61:643-644, 1984 (editorial)
Crozier TA, Schlaeger M., Wuttke W., Kettler D.: [TIVA with etomidate-fentanyl versus midazolam-fentanyl. The perioperative stress of coronary surgery overcomes the inhibition of cortisol synthesis caused by etomidatefentanyl anesthesia]. [German] TIVA mit Etomidat-Fentanyl versus Midazolam-Fentanyl. Der perioperative Stress der Koronarchirurgie uberwindet die Kortisolsynthesehemmung nach einer totalen in travenosen Anasthesie mit Etomidat-Fentanyl. Anaesthesist43:605-613, 1994
90.
Urquhart MI , White PF: Comparison of sedative infusions during regional anesthesia: Methohexital, etomidate, and midazolam [published erratum appears in Anesth Analg1989 Apr;68:550]. Anesth Analg68:249-254, 1989
91.
Holdcroft A. , Morgan M., Whitwam JG, Lumley J.: Effect of dose and premedication on induction complications with etomidate. Br J Anaesth48:199-205, 1976
92.
Fragen RJ, Caldwell N.: Comparison of a new formulation of etomidate with thiopental: Side effects and awakening times. Anesthesiology50:242-244, 1979
93.
Wells JK: Comparison of ICI 35868, etomidate and methohexitone for day-case anaesthesia . Br J Anaesth57:732-735, 1985
94.
White PF: Continuous infusions of thiopental, methohexital, or etomidate as adjuvants to nitrous oxide for outpatient anesthesia. Anesth Analg63:282, 1984
95.
Van Hemelrijck J, Gonzaless JM, White PF: Use of intravenous sedative agents, chapter 53, in Rogers M, Tinker J, Covino B, Longnecker D (eds): Principle and Practice of Anesthesiology, St. Louis, MO, Mosby, 1992, pp 1131-1154
96.
Zacharias M. , Dundee JW, Clarke RS, Hegarty JE: Effect of preanaesthetic medication on etomidate . Br J Anaesth51:127-133, 1979
97.
Gran L., Bleie H., Jeppson R., Maartmann-Moe H: [Etomidate in Intralipid. A solution for pain-free injection]. [German] Etomidat mit Intralipid. Eine Losung zur schmerzfreien Injektion . Anaesthesist32:475-477, 1983
